To determine the ability of ATN-224 to overcome apoptosis-resistance, we characterized three DLBCL cell lines for the anti-apoptotic proteins, Bcl-2, Bcl-xL and Mcl-1. The gene discussed is BCL2L1; the disease is diffuse large B-cell lymphoma.